Display Settings:

Format

Send to:

Choose Destination
Accession: PRJNA391720 ID: 391720

Pharmacodynamics, Safety, and Clinical Efficacy of AMG 811, a Human Anti-Interferon-γ Antibody, in Patients With Discoid Lupus Erythematosus

This SuperSeries is composed of the SubSeries listed below. Overall design: Refer to individual Series
AccessionPRJNA391720; GEO: GSE100431
TypeUmbrella project
PublicationsWerth VP et al., "Brief Report: Pharmacodynamics, Safety, and Clinical Efficacy of AMG 811, a Human Anti-Interferon-γ Antibody, in Patients With Discoid Lupus Erythematosus.", Arthritis Rheumatol, 2017 May;69(5):1028-1034
SubmissionRegistration date: 23-Jun-2017
Molecular Sciences, Amgen Inc.
RelevanceSuperseries
Project Data:
Resource NameNumber
of Links
Publications
PubMed1
PMC1
Other datasets
GEO DataSets3
GEO Data Details
ParameterValue
Data volume, Spots8239580
Data volume, Processed Mbytes147
Data volume, Supplementary Mbytes5339
Pharmacodynamics, Safety, and Clinical Efficacy of AMG 811, a Human Anti-Interferon-γ Antibody, in Patients With Discoid Lupus Erythematosus encompasses the following 2 sub-projects:
Project TypeNumber of Projects
Transcriptome or Gene expression2
BioProject
accession
OrganismTitle
PRJNA391723Homo sapiensPharmacodynamics, Safety, and Clinical Efficacy of AMG 811, a Human Anti-Interferon-γ Antibody, in Patients With Discoid Lupus Erythematosus [blood] (Molecular Sciences, Amgen...)
PRJNA390658Homo sapiensPharmacodynamics, Safety, and Clinical Efficacy of AMG 811, a Human Anti-Interferon-γ Antibody, in Patients With Discoid Lupus Erythematosus [skin] (Molecular Sciences, Amgen...)

Supplemental Content

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
Support Center